LeadIQ logo
Learn more at LeadIQ.com

Insights

Expansion Opportunities Recent acquisitions like the $96.4M purchase by Rise48 Equity, LLC indicate potential growth and expansion avenues for Portola Pharmaceuticals, presenting opportunities for new partnerships and business development initiatives.

Successful Product Launches The successful launch of Andexxa in 2018, accounting for over 34% of quarter-over-quarter growth, showcases Portola's ability to bring innovative products to market, highlighting potential sales success and market penetration strategies.

High Revenue Generation With an annual revenue between $50M - $100M and a funding of $259M, Portola Pharmaceuticals demonstrates strong financial health, providing a solid foundation for potential sales growth and investment opportunities.

Key Personnel Moves Notable departures of key executives like Mahal, Dier, and Meyer signal a potential need to strengthen leadership positions within the company, creating openings for sales professionals to build new relationships and collaborations.

Legal Concerns Resolution Addressing issues related to possible breaches of fiduciary duty and other violations, such as those investigated by Ademi & O'Reilly, LLP, could enhance Portola's reputation and credibility, paving the way for improved sales prospects and investor confidence.

Portola Pharmaceuticals Tech Stack

Portola Pharmaceuticals uses 8 technology products and services including Matomo, Practice Fusion, jQuery UI, and more. Explore Portola Pharmaceuticals's tech stack below.

  • Matomo
    Analytics
  • Practice Fusion
    Electronic Health Records
  • jQuery UI
    Javascript Libraries
  • Splunk
    Miscellaneous
  • WP Engine
    Platform As A Service
  • Python
    Programming Languages
  • Adobe Creative Suite
    Visualisation Software
  • Facebook
    Widgets

Media & News

Portola Pharmaceuticals's Email Address Formats

Portola Pharmaceuticals uses at least 1 format(s):
Portola Pharmaceuticals Email FormatsExamplePercentage
FLast@portola.comJDoe@portola.com
47%
First.Last@portola.comJohn.Doe@portola.com
6%
FLast@portola.comJDoe@portola.com
47%

Frequently Asked Questions

Where is Portola Pharmaceuticals's headquarters located?

Minus sign iconPlus sign iconPortola Pharmaceuticals's main headquarters is located at 270 East Grand Ave. South San Francisco, CA 94080 US. The company has employees across 4 continents, including North AmericaEuropeAsia.

What is Portola Pharmaceuticals's phone number?

Minus sign iconPlus sign icon You can contact Portola Pharmaceuticals's main corporate office by phone at
+1-650-246-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Portola Pharmaceuticals's stock symbol?

Minus sign iconPlus sign iconPortola Pharmaceuticals is a publicly traded company; the company's stock symbol is PTLA.

What is Portola Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign iconPortola Pharmaceuticals's official website is portola.com and has social profiles on LinkedIn.

How much revenue does Portola Pharmaceuticals generate?

Minus sign iconPlus sign icon As of March 2024, Portola Pharmaceuticals's annual revenue reached $75M.

What is Portola Pharmaceuticals's SIC code NAICS code?

Minus sign iconPlus sign iconPortola Pharmaceuticals's SIC code is 3544 - Special Dies and Tools, Die Sets, Jigs and Fixtures, and Industrial Molds NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Portola Pharmaceuticals have currently?

Minus sign iconPlus sign iconAs of March 2024, Portola Pharmaceuticals has approximately 201 employees across 4 continents, including North AmericaEuropeAsia. Key team members include CEO: V. G.Vice President Sales: R. S. L.Head Data Management & Biostatistics: B. A.. Explore Portola Pharmaceuticals's employee directory with LeadIQ.

What industry does Portola Pharmaceuticals belong to?

Minus sign iconPlus sign iconPortola Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Portola Pharmaceuticals use?

Minus sign iconPlus sign iconPortola Pharmaceuticals's tech stack includes MatomoPractice FusionjQuery UISplunkWP EnginePythonAdobe Creative SuiteFacebook.

What is Portola Pharmaceuticals's email format?

Minus sign iconPlus sign iconPortola Pharmaceuticals's email format typically follows the pattern of . Find more Portola Pharmaceuticals email formats with LeadIQ.

How much funding has Portola Pharmaceuticals raised to date?

Minus sign iconPlus sign icon As of March 2024, Portola Pharmaceuticals has raised $259M in funding. The last funding round occurred on Aug 13, 2019 for $259M.

When was Portola Pharmaceuticals founded?

Minus sign iconPlus sign iconPortola Pharmaceuticals was founded in 2003.
Portola Pharmaceuticals

Portola Pharmaceuticals

Pharmaceutical ManufacturingCalifornia, United States201-500 Employees

We are focused on the discovery, development and commercialization of novel therapeutics that could significantly advance the fields of thrombosis and other hematologic conditions.
 
The Company's first two commercialized products are Andexxa® [coagulation factor Xa (recombinant), inactivated-zhzo], marketed in Europe as Ondexxya® (andexanet alfa), and Bevyxxa® (betrixaban). The company also is advancing cerdulatinib, an investigational SYK/JAK inhibitor being developed for the treatment of hematologic cancers.
 
We are continuing to explore new discoveries that impact how serious blood-related disorders are treated and expanding the potential impact of our existing portfolio of medicines.

Section iconCompany Overview

Headquarters
270 East Grand Ave. South San Francisco, CA 94080 US
Phone number
+1-650-246-****
Website
portola.com
SIC Code
3544 - Special Dies and Tools, Die Sets, Jigs and Fixtures, and Industrial Molds
Stock Symbol
PTLA
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2003
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $259M

    Portola Pharmaceuticals has raised a total of $259M of funding over 11 rounds. Their latest funding round was raised on Aug 13, 2019 in the amount of $259M.

  • $50M$100M

    Portola Pharmaceuticals's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $259M

    Portola Pharmaceuticals has raised a total of $259M of funding over 11 rounds. Their latest funding round was raised on Aug 13, 2019 in the amount of $259M.

  • $50M$100M

    Portola Pharmaceuticals's revenue is in the range of $50M$100M

Company Leadership

  • Stylized image of a person
    V. G.
    CEO
    Phone icon
    Mobile Phone
  • Stylized image of a person
    R. S. L.
    Vice President Sales
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. A.
    Head Data Management & Biostatistics
    Phone icon
    Mobile Phone
  • Stylized image of a person
    G. G.
    Board Chairman
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. L.
    Executive Director, Head Of Global Total Rewards
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    J. C.
    Senior Vice President, Regulatory Affairs
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. L.
    Senior Vice President, Nonclinical And Pharmaceutical Development
    Phone icon
    Mobile Phone
  • Stylized image of a person
    S. G.
    Vice President, Marketing
    Phone icon
    Mobile Phone
  • Stylized image of a person
    W. D.
    Senior Vice President - Business Development And Alliance Management
    Phone icon
    Mobile Phone
  • Stylized image of a person
    G. L.
    Senior Director Of Biology
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.